Anna Planagumà
Impact in
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
- Hepatology top 5%
- Liver Disease and Transplantation
- Liver physiology and pathology
Papers in
-
- Inflammatory mediators and NSAID effects 7
- Drug-Induced Hepatotoxicity and Protection 4
-
- Eicosanoids and Hypertension Pharmacology 6
- Co-authors
- Joan Clària (16 shared papers)Vicente Arroyo (15 shared papers)Marta López‐Parra (13 shared papers)Esther Titos (13 shared papers)Rosa Miquel (7 shared papers)Ana González‐Périz (6 shared papers)Bruce D. Levy (3 shared papers)Juan Rodés (4 shared papers)
- Journals
- Journal of Hepatology (4 papers)The FASEB Journal (4 papers)Clinical & Experimental Immunology (1 paper)PLoS ONE (1 paper)Journal of Lipid Research (1 paper)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Anna Planagumà
23 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 83
- Biochemistry 264
- Hepatology 200
- Nutrition and Dietetics 283
- Pharmacology 212
- Pharmacology 103
Countries citing papers authored by Anna Planagumà
This map shows the geographic impact of Anna Planagumà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Planagumà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Planagumà more than expected).
Fields of papers citing papers by Anna Planagumà
This network shows the impact of papers produced by Anna Planagumà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Planagumà. The network helps show where Anna Planagumà may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Planagumà, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 188 | |
| 2 | 2008 | 187 | |
| 3 | 2002 | 169 | |
| 4 | 2005 | 114 | |
| 5 | 2013 | 85 | |
| 6 | 2010 | 84 | |
| 7 | 2003 | 65 | |
| 8 | 2009 | 64 | |
| 9 | 2005 | 51 | |
| 10 | 2007 | 48 | |
| 11 | 2008 | 45 | |
| 12 | 2002 | 45 | |
| 13 | 2015 | 37 | |
| 14 | 2002 | 36 | |
| 15 | 2004 | 17 | |
| 16 | 2013 | 15 | |
| 17 | 2005 | 14 | |
| 18 | 2008 | 10 | |
| 19 | 2018 | 8 | |
| 20 | 2004 | 3 |
About Anna Planagumà
Anna Planagumà is a scholar working on Pharmacology, Biochemistry, Physiology, Hepatology and Molecular Biology, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Liver physiology and pathology (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Asthma and respiratory diseases (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Biochemistry (264 citations), Hepatology (200 citations), Nutrition and Dietetics (283 citations), Pharmacology (212 citations) and Pharmacology (103 citations). Anna Planagumà has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Joan Clària, Vicente Arroyo, Marta López‐Parra, Esther Titos, Rosa Miquel, Ana González‐Périz, Bruce D. Levy, Juan Rodés, Natàlia Ferré and Raquel Horrillo. Their work appears in journals such as Journal of Hepatology, The FASEB Journal, Clinical & Experimental Immunology, PLoS ONE and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.